A cost figure with a credible story behind it
Therabody, the wellness-technology company known for its percussive therapy devices, reported a 45% reduction in technology costs after consolidating its financial systems onto Oracle NetSuite. The company operates across more than 60 countries and processes thousands of orders daily during peak periods, a scale at which fragmented regional systems compound into real operating cost rather than remaining a manageable inconvenience. That combination, global footprint plus high order volume, is exactly the profile where financial-system consolidation tends to produce the largest measurable savings.
CTO Yash Murali framed the change in operational rather than purely financial terms: 'With rapid growth, we've seen firsthand how a complex technology stack becomes difficult to scale. NetSuite has helped us bring our operations together with AI capabilities that simplify and accelerate workflows.' That framing matters for how other technology leaders should read the case study, the cost savings followed from an operational fix, consolidating fragmented systems, rather than from a cost-cutting initiative pursued for its own sake.
What was actually replaced
Therabody had been running separate financial systems per region, the kind of setup that accumulates naturally as a fast-growing company expands into new geographies faster than it standardizes its back-office tooling. Each regional system typically means separate implementation costs, separate maintenance contracts, separate integration work with everything else in the stack, and a finance team that has to reconcile data across systems that were never designed to talk to each other cleanly, month after month, quarter close after quarter close.
That fragmentation is common enough among PE-backed and high-growth companies that it barely registers as a problem until someone totals the actual cost of running it. Therabody's case is useful precisely because the total is now public: a 45% reduction gives other CFOs and CIOs a real number to test their own fragmented-systems cost against, rather than relying on a vendor's generic ROI calculator built for a hypothetical company that never quite matches the buyer's own situation.
The consolidation came before the AI capability, not after
The deployment's architecture is worth studying closely: NetSuite OneWorld handled multi-subsidiary financial management across North America, Europe, and Asia Pacific first, and Advanced Order Management automated order-to-fulfillment workflows on top of that unified base. The AI Connector Service, which supports natural-language queries and workflow automation through Model Context Protocol, sits on top of both, not ahead of them.
That sequencing is the transferable lesson for CIOs currently evaluating AI tooling against fragmented back-office data. An AI layer promising natural-language queries or workflow automation cannot deliver much value sitting on top of data spread across multiple disconnected regional systems, since the queries themselves would need to reconcile inconsistent formats and definitions before returning a trustworthy answer. Therabody's results suggest the consolidation work has to happen first, with the AI capability arriving as a genuine multiplier on a unified base rather than a substitute for doing that unification work, no matter how the platform is marketed.
The build-versus-consolidate decision this validates
For a CFO or CIO facing the same regional-system sprawl Therabody had, the decision this case study speaks to directly is whether to keep patching point solutions region by region or to consolidate onto a single platform capable of handling the full footprint. Point solutions are often individually cheaper and faster to deploy in a single region, which is exactly why they proliferate during rapid international expansion, but the cumulative cost of running and integrating many of them eventually exceeds the cost of a harder, slower consolidation project.
Therabody's 45% figure is not a guarantee any other company will see the same number, savings depend heavily on how fragmented the starting state actually was. But it is a real, publicly attributable data point from a company operating at meaningful international scale, which makes it more useful for a board-level business case than a vendor-supplied benchmark drawn from an unnamed customer average buried in a marketing deck.
What to ask before starting a similar consolidation
CIOs considering a comparable move should start by mapping exactly which regional systems exist, what each one actually costs including the integration and maintenance work nobody bills separately, and how much of the finance team's time goes into manual reconciliation across systems that should be talking to each other automatically. That mapping exercise alone often surfaces enough hidden cost to build a credible business case, independent of whatever number a vendor eventually quotes for the target platform.
The second question is sequencing: whether the AI and automation capabilities being pitched alongside the platform migration are realistic to activate immediately, or whether, as in Therabody's case, they only become genuinely useful once the underlying data consolidation is substantially complete. Buyers who budget and communicate the AI layer as a later-phase benefit, rather than an immediate feature, will set more accurate expectations with their own leadership and avoid a credibility gap when day-one AI usage falls short of the pitch made during the sales cycle.
